AI assistant
Sending…
Whitehawk Therapeutics, Inc. — Director's Dealing 2017
Mar 17, 2017
34276_dirs_2017-03-17_420ed200-39f7-4f6c-88a3-6b7c7c310954.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aerpio Pharmaceuticals, Inc. (NONE)
CIK: 0001422142
Period of Report: 2017-03-15
Reporting Person: PETERS KEVIN G. (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-15 | Common Stock | P | 3642 | $5.00 | Acquired | 320536 | Direct |
More from Whitehawk Therapeutics, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Capital/Financing Update
2026
May 13
Report Publication Announcement
2026
May 7
Director's Dealing
2025
Dec 2
Director's Dealing
2025
Dec 2
Regulatory Filings
2025
Nov 6
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Aug 25
Earnings Release
2025
Aug 7